Quantitative Infarct Volumetry Outperforms ASPECTS in Large-Core Stroke: Study

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2026-07-23 12:49 GMT   |   Update On 2026-07-23 12:49 GMT

According to new research, among patients with large-core ischemic stroke undergoing thrombectomy, quantitative infarct volumetry was a more accurate predictor of biological infarct burden and clinical outcomes than the Alberta Stroke Program Early CT Score (ASPECTS). It was found that Infarct volumes >110 mL identified a threshold beyond which the benefit of reperfusion markedly diminished, supporting volumetry as a superior tool for patient selection. The study was published in the AHA Stroke journal by Hokyu K. and colleagues.

The investigation examined the imaging and clinical data on patients who underwent acute thrombectomy in an emergency setting for a period of several years between 2022 and 2024. Researchers carefully studied the structural discrepancy between ASPECTS scores based on regular CT images and automatically obtained volumetric parameters measured simultaneously on diffusion-weighted imaging (DWI), computed tomography perfusion (CTP), and conventional noncontrast computed tomography (NCCT).

The main outcome criterion in the predictive models was poor neurological function 90 days after stroke onset (modified Rankin Scale score from 5 to 6). To estimate the exact causal effect of treatment for particular volume values, the statistical team devised advanced emulation of a target trial with stratification of the estimates of the intervention according to volumetric cut-offs and global score change on the ordinal 90-day modified Rankin Scale.

Key findings:

  • The nationwide validation study of neuro-interventional procedures was able to process and analyze data in terms of the baseline sample consisting of 552 patients.
  • Mapped participants showed a mean age of 70.4 ± 12.6 years with predominance among males, making up 319 people or 57.8% of the entire sample.
  • The patients, categorized as having a large core infarction based on ASPECTS criteria alone without volumetry of diffusion-weighted imaging, had low percentages of poor 90-day functional outcome at 11.8% that was almost identical to the true volumetric small core baseline of 11.7%.
  • Inconsistently large core infarct volume, as confirmed by DWI, CTP, and NCCT, irrespective of high ASPECTS score, predicted poor clinical outcomes with an astonishing adjusted odds ratio of 6.92 (95% CI, 2.58–19.34) for patients with large cores defined by DWI only.
  • Regarding the global target trial emulation models, the efficacy of mechanical thrombectomy treatment seemed to be reduced with a common odds ratio of 0.56 (95% CI, 0.31–1.03).
  • Stratified target analysis confirmed the robust clinical benefit of clot retrieval therapy in an intermediate core volume of 50 to 110 mL range with a remarkable common odds ratio of 0.38 (95% CI, 0.15–0.97).

In summary, volumetric quantification offered more accurate discrimination and recognized ischemic volumes of 110 mL or higher as a threshold at which the benefits of thrombectomy therapy would be too minimal. The results support the inclusion of volumetric thresholds within the selection process in order to avoid futile reperfusion, thus ensuring safety, thereby representing a necessary improvement on the present topographical classification.

Reference:

Kim, H., Ryu, W.-S., Inoue, M., Sunwoo, L., Kang, K., Kim, J. G., Lee, S. J., Cha, J.-K., Park, T. H., Lee, J.-Y., Lee, K., Kwon, D. H., Lee, J., Park, H.-K., Hong, K.-S., Lee, M., Oh, M. S., Yu, K.-H., Gwak, D.-S., … Kim, B.-J. (2026). Defining the Therapeutic Ceiling of Endovascular Thrombectomy in Large-Core Stroke: Beyond the Limits of ASPECTS. Stroke. https://doi.org/10.1161/strokeaha.126.055374


Tags:    
Article Source : AHA Stroke journal

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News